Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06506942 · ClinicalTrials.gov registry record · NA
The TRICURE EFS Study
A NA study of Cardiovascular Diseases and Heart Valve Diseases, sponsored by TRiCares.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 8
- Study locations
NCT06506942: Recruiting NA study of Cardiovascular Diseases and Heart Valve Diseases, sponsored by TRiCares.
NCT06506942 is a NA study of Cardiovascular Diseases and Heart Valve Diseases that is actively recruiting participants, run by TRiCares. The registered enrollment target is 15 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 8 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06506942, a NA study of Cardiovascular Diseases and Heart Valve Diseases, is actively recruiting participants, sponsored by TRiCares.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 8
- Study locations
Study Summary
Prospective, multi-center study to assess safety and performance of the TRiCares Topaz Tricuspid Valve Replacement System
Primary Outcome
Composite rate of major adverse events (MAEs) at 30 days, including mortality, myocardial infarction, stroke and major complications.
Conditions Studied
Interventions
- DEVICE Transcatheter Tricuspid Valve Replacement
Study Locations (8)
New York
- Columbia University Medical Center/ NewYork Presbyterian Hospital - New York
- Montefiore - The Bronx
Georgia
- Piedmont Healthcare Inc. - Atlanta
Illinois
- Northwestern - Chicago
Michigan
- University of Michigan Hospital and Health Systems - Ann Arbor
Minnesota
- Minneapolis Heart Institute Foundation - Minneapolis
Ohio
- The Christ Hospital - Cincinnati
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2024-09-11 |
| Est. Completion | 2031-03 |
| Phase | NA |
What NCT06506942 shows while recruiting
NCT06506942 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower).
The record links to 3 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Transcatheter Tricuspid Valve Replacement is the first listed.
NCT06506942 lists 8 locations in 7 states (New York, Georgia, Illinois).
Frequently Asked Questions
What is clinical trial NCT06506942 about?
NCT06506942 is a clinical study titled "The TRICURE EFS Study". Prospective, multi-center study to assess safety and performance of the TRiCares Topaz Tricuspid Valve Replacement System
What is the current status of trial NCT06506942?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2024-09-11. Estimated completion is 2031-03.
What conditions does trial NCT06506942 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Heart Valve Diseases, Tricuspid Valve Regurgitation.
What interventions are being tested in trial NCT06506942?
The interventions under investigation include: Transcatheter Tricuspid Valve Replacement (DEVICE).
Who is sponsoring clinical trial NCT06506942?
This trial is sponsored by TRiCares, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06506942 being conducted?
This trial has 8 study locations across Georgia, Illinois, Michigan, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06506942's enrollment target sits among peer trials
15 289th of 300 higher than 10 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI